The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016 / A. Antinori, A. Di Biagio, S. Marcotullio, M. Andreoni, A. Chirianni, A. d'Arminio Monforte, M. Galli, F. Mazzotta, C. Mussini, M. Puoti, A. Lazzarin. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017 Apr), pp. 86-98.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016

A. d'Arminio Monforte;M. Galli;A. Lazzarin
2017

Abstract

The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.
No
English
Guidelines; HIV; Italy; antiretroviral agents; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Health Policy; Italy; HIV-1; Practice Guidelines as Topic
Settore MED/07 - Microbiologia e Microbiologia Clinica
Articolo
Esperti anonimi
Pubblicazione scientifica
apr-2017
Ponzio
40
2
86
98
13
Pubblicato
Periodico con rilevanza internazionale
http://www.newmicrobiologica.org/PUB/allegati_pdf/2017/2/86.pdf
Aderisco
info:eu-repo/semantics/article
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016 / A. Antinori, A. Di Biagio, S. Marcotullio, M. Andreoni, A. Chirianni, A. d'Arminio Monforte, M. Galli, F. Mazzotta, C. Mussini, M. Puoti, A. Lazzarin. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017 Apr), pp. 86-98.
open
Prodotti della ricerca::01 - Articolo su periodico
11
262
Article (author)
Periodico con Impact Factor
A. Antinori, A. Di Biagio, S. Marcotullio, M. Andreoni, A. Chirianni, A. d'Arminio Monforte, M. Galli, F. Mazzotta, C. Mussini, M. Puoti, A. Lazzarin...espandi
File in questo prodotto:
File Dimensione Formato  
86.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 496.68 kB
Formato Adobe PDF
496.68 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/623249
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 28
social impact